Capital Flow Monitor · Sponsors · CIK 1943737
Pheast Therapeutics, Inc.
200 CARDINAL WAY, STE 300, REDWOOD CITY, CA, 94063 · 650-374-2223
Other Technology · Corporation· inc. DELAWARE true 2020
Fit score
—
Offering
$40.0M
Sold
$24.6M
% sold
61.5%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-16 | D ·current | 506(b) | $40.0M | $24.6M | 61.5% | 7 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Roy Maute — Executive Officer / Director, Redwood City, CA
- Amira Barkal — Director, Redwood City, CA
-
Steven Gillis — Director, Redwood City, CA
2 other raises
- ARCH Venture Fund XIV, L.P. $0 of $3.0B · 0.0%
- SonoThera, Inc. $125.5M of $125.5M · 100.0%
- Jacob Vogelstein — Director, Redwood City, CA
- Thomas Marty — Executive Officer, Redwood City, CA
- Raphael Rousseau — Executive Officer, Redwood City, CA
- Irving Weissman — Director, Redwood City, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.